Péron J - Search Results

1

Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases.

Schell F, Kefleyesus A, Benzerdjeb N, Passot G, Rousset P, Omar A, Villeneuve L, Péron J, Glehen O, Kepenekian V. Schell F, et al. Among authors: peron j. Ann Surg Oncol. 2023 Jul;30(7):4444-4454. doi: 10.1245/s10434-023-13279-9. Epub 2023 Mar 2. Ann Surg Oncol. 2023. PMID: 36864324

2

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors.

Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Quénet F, Eveno C, Pocard M, Goere D, Elias D, Ortega-Deballon P, Vaudoyer D, Cotte E, Glehen O. Charrier T, et al. Among authors: peron j. Ann Surg Oncol. 2016 Jul;23(7):2315-22. doi: 10.1245/s10434-016-5143-1. Epub 2016 Feb 26. Ann Surg Oncol. 2016. PMID: 26920385

3

Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.

Chirac P, Maillet D, Leprêtre F, Isaac S, Glehen O, Figeac M, Villeneuve L, Péron J, Gibson F, Galateau-Sallé F, Gilly FN, Brevet M. Chirac P, et al. Among authors: peron j. Hum Pathol. 2016 Sep;55:72-82. doi: 10.1016/j.humpath.2016.04.015. Epub 2016 May 14. Hum Pathol. 2016. PMID: 27184482

4

The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis.

Péron J, Mercier F, Tuech JJ, Younan R, Sideris L, Gelli M, Dumont F, Le Roy B, Sgarbura O, Lo Dico R, Bibeau F, Glehen O, Passot G; on behalf BIG-RENAPE working groups. Péron J, et al. Surgery. 2019 Feb;165(2):476-484. doi: 10.1016/j.surg.2018.07.027. Epub 2018 Sep 7. Surgery. 2019. PMID: 30197280

5

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET).

Lemelin A, Barritault M, Hervieu V, Payen L, Péron J, Couvelard A, Cros J, Scoazec JY, Bin S, Villeneuve L, Lombard-Bohas C, Walter T; MGMT-NET investigators. Lemelin A, et al. Among authors: peron j. Dig Liver Dis. 2019 Apr;51(4):595-599. doi: 10.1016/j.dld.2019.02.001. Epub 2019 Feb 14. Dig Liver Dis. 2019. PMID: 30824408

6

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.

Lurvink RJ, Villeneuve L, Govaerts K, de Hingh IHJT, Moran BJ, Deraco M, Van der Speeten K, Glehen O, Kepenekian V, Kusamura S; List of PSOGI collaborators. Lurvink RJ, et al. Eur J Surg Oncol. 2021 Jan;47(1):4-10. doi: 10.1016/j.ejso.2019.03.012. Epub 2019 Mar 23. Eur J Surg Oncol. 2021. PMID: 30954350 Review.

7

Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and Perspectives.

Reverdy T, Sajous C, Péron J, Glehen O, Bakrin N, Gertych W, Lopez J, You B, Freyer G. Reverdy T, et al. Among authors: peron j. Cancers (Basel). 2020 Aug 25;12(9):2414. doi: 10.3390/cancers12092414. Cancers (Basel). 2020. PMID: 32854393 Free PMC article. Review.

8

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort.

Kepenekian V, Péron J, Goéré D, Sgarbura O, Delhorme JB, Eveno C, Benzerdjeb N, Bonnefoy I, Villeneuve L, Rousset P, Abboud K, Pocard M, Glehen O; On Behalf RENAPE (French Network for Rare Peritoneal Malignancies). Kepenekian V, et al. Among authors: peron j. Int J Hyperthermia. 2021;38(1):805-814. doi: 10.1080/02656736.2021.1903585. Int J Hyperthermia. 2021. PMID: 34039244 Free article.

9

ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection.

Kepenekian V, Péron J, You B, Glehen O. Kepenekian V, et al. Among authors: peron j. Ann Surg Oncol. 2022 Mar;29(3):2114-2115. doi: 10.1245/s10434-021-10990-3. Epub 2021 Oct 27. Ann Surg Oncol. 2022. PMID: 34705141 No abstract available.

10

Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.

Kepenekian V, Péron J, You B, Bonnefoy I, Villeneuve L, Alyami M, Bakrin N, Rousset P, Benzerdjeb N, Glehen O. Kepenekian V, et al. Among authors: peron j. Ann Surg Oncol. 2022 Mar;29(3):2104-2113. doi: 10.1245/s10434-021-10983-2. Epub 2021 Oct 28. Ann Surg Oncol. 2022. PMID: 34713369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page